Global Bioabsorbable Stent/Bioresorbable Scaffold Market

1 INTRODUCTION OF GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY ABSORPTION RATE
5.1 Slow Absorption rate
5.2 Fast absorption rate

6 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY MATERIAL
6.1 Bioresorbable Polymer-Based Stents
6.2 Bioresorbable Metallic Stents

7 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY END USER
7.1 Hospitals
7.2 Cardiac Centers

8 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY APPLICATION
8.1 Coronary Artery Disease
8.2 Peripheral Artery Disease

9 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

10 GLOBAL BIOABSORBABLE STENT/BIORESORBABLE SCAFFOLD MARKET COMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Abbott
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 REVA Medical, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Elixir Medical Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Kyoto Medical Planning Co., Ltd.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 BIOTRONIK
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Amaranth Medical, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Arterial Remodeling Technologies
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Meril Life Sciences Pvt. Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Arterius Limited
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Boston Scientific Corporation
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 480 Biomedical
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 S3V Vascular Technologies Private Limited
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

11.14 Qualimed
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments

11.15 ORBUSNEICH
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments

12 Appendix
12.1 Related Reports